# Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis

> **NCT02263066** · — · COMPLETED · sponsor: **Bayer** · enrollment: 181 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** BAY14-2222_Kogenate-FS FVIII

## Key facts

- **NCT ID:** NCT02263066
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2015-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02263066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02263066, "Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02263066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*